Medtronic plc recently announced that the US Food and Drug Administration (FDA) has granted premarket approval for its Deep Brain Stimulation (DBS) therapy as adjunctive treatment for reducing the frequency of partial-onset epileptic seizures, in individuals ≥18 years who are refractory, or drug-resistant, to ≥3 antiepileptic medications. Medtronic plc is headquartered in Dublin, Ireland.
DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus (ANT), which is part of a network involved in seizures. It uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver electrical stimulation to precisely targeted areas of the brain as adjunctive treatment for several neurological disorders.
Medtronic receives FDA approval for deep brain stimulation therapy for medically refractory epilepsy. [news release]. May 1, 2018. Dublin, Ireland: Medtronic plc. http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2345882. Accessed May 3, 2018.
This Week's Must Reads
Cortical Dynamics in Essential Tremor Examined, Mov Disord; ePub 2018 Oct 21; Roy, et al
Distinguishing PD from PSP Through Biomarker, J Parkinsons Dis; 2018 Oct; Bottero, et al
Self-Reported Activity in Veterans with PD is Low, Parkinsonism Relat Disord; ePub 2018 Oct 23; Mantri, et al
End-Of-Life Experiences in Dementia with Lewy Bodies, J Am Geriatr Soc; ePub 2018 Oct 6; Armstrong, et al
First-Degree Kin of Patients with ET and Cognition, Parkinsonism Relat Disord; ePub 2018 Oct 30; Meyers, et al
Must Reads in Epilepsy & Seizures
Unplanned Pregnancy, Fetal Loss, and Epilepsy, JAMA Neurology; ePub 2018 Oct 15; Herzog, et al
Probable OSA Common in Refractory Epilepsy, Epilepsia; ePub 2018 Sep 24; McCarter, et al
Circadian, Circaseptan Rhythms in Epilepsy Examined, Lancet Neurol; ePub 2018 Sep 12; Karoly, et al
Epilepsy Transition Care Gap in Young Adults, Epilepsy Behav; ePub 2018 Aug 25; Baca, et al
FDA Approves Diacomit for Treatment of Seizures, Biocodex news release; 2018 Aug 23